Kornitzer Capital Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-16,470
Closed -$1.15M 508
2022
Q1
$1.15M Hold
16,470
0.02% 411
2021
Q4
$1.28M Buy
16,470
+125
+0.8% +$11K 0.02% 419
2021
Q3
$1.56M Sell
16,345
-50
-0.3% -$5.28K 0.02% 406
2021
Q2
$2.04M Buy
16,395
+25
+0.2% +$2.98K 0.03% 372
2021
Q1
$2.16M Sell
16,370
-50
-0.3% -$6.84K 0.03% 347
2020
Q4
$2.17M Hold
16,420
0.04% 341
2020
Q3
$1.67M Buy
+16,420
New +$1.42M 0.03% 343
2020
Q2
Sell
-12,881
Closed -$747K 502
2020
Q1
$747K Sell
12,881
-289,382
-96% -$23.5M 0.02% 411
2019
Q4
$28M Buy
302,263
+104,530
+53% +$9.19M 0.49% 61
2019
Q3
$17.9M Sell
197,733
-93,567
-32% -$10.7M 0.32% 105
2019
Q2
$34.4M Buy
291,300
+73,135
+34% +$7.37M 0.61% 44
2019
Q1
$18.9M Buy
218,165
+161,640
+286% +$13.8M 0.34% 102
2018
Q4
$3.57M Sell
56,525
-169,703
-75% -$11.6M 0.07% 263
2018
Q3
$17.9M Sell
226,228
-31,221
-12% -$2.04M 0.28% 124
2018
Q2
$15.4M Buy
257,449
+31,414
+14% +$1.69M 0.26% 125
2018
Q1
$9.12M Buy
226,035
+47,945
+27% +$2.34M 0.16% 183
2017
Q4
$9.36M Sell
178,090
-106,250
-37% -$5.67M 0.16% 182
2017
Q3
$13.4M Sell
284,340
-51,780
-15% -$2.08M 0.23% 134
2017
Q2
$11.9M Sell
336,120
-136,980
-29% -$4.23M 0.21% 156
2017
Q1
$11.2M Sell
473,100
-318,865
-40% -$6.32M 0.2% 159
2016
Q4
$10.6M Buy
791,965
+83,745
+12% +$1.35M 0.2% 166
2016
Q3
$13.2M Sell
708,220
-93,775
-12% -$1.65M 0.24% 147
2016
Q2
$9.82M Buy
+801,995
New +$6.04M 0.18% 181

Other funds holding EXAS

Kornitzer Capital Management's EXAS Position: Q2 2022 in Review

Kornitzer Capital Management sold out of Exact Sciences (EXAS) in Q2 2022, closing a stake of 16,470 shares — an estimated $1.15M sold.

Kornitzer Capital Management first reported a position in EXAS in Q2 2016 and held it in 23 quarters. The position peaked at $34.4M in Q2 2019. 501 funds tracked by Wall St. Rank hold EXAS as of Q2 2022.

  • Kornitzer Capital Management reported no remaining Exact Sciences position as of Q2 2022 after selling out during the quarter.
  • Kornitzer Capital Management sold 16,470 Exact Sciences shares in Q2 2022, an estimated $1.15M.
  • Kornitzer Capital Management first reported a position in Exact Sciences in Q2 2016 and held it in 23 quarters.
  • Kornitzer Capital Management's Exact Sciences position peaked at $34.4M in Q2 2019.
  • 501 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2022.

Based on Kornitzer Capital Management's 13F filing for Q2 2022, filed 3 Aug 2022.